Tumor necrosis factor receptor and Fas signaling mechanisms - PubMed (original) (raw)
Review
Tumor necrosis factor receptor and Fas signaling mechanisms
D Wallach et al. Annu Rev Immunol. 1999.
Abstract
Four members of the tumor necrosis factor (TNF) ligand family, TNF-alpha, LT-alpha, LT-beta, and LIGHT, interact with four receptors of the TNF/nerve growth factor family, the p55 TNF receptor (CD120a), the p75 TNF receptor (CD120b), the lymphotoxin beta receptor (LT beta R), and herpes virus entry mediator (HVEM) to control a wide range of innate and adaptive immune response functions. Of these, the most thoroughly studied are cell death induction and regulation of the inflammatory process. Fas/Apo1 (CD95), a receptor of the TNF receptor family activated by a distinct ligand, induces death in cells through mechanisms shared with CD120a. The last four years have seen a proliferation in knowledge of the proteins participating in the signaling by the TNF system and CD95. The downstream signaling molecules identified so far--caspases, phospholipases, the three known mitogen activated protein (MAP) kinase pathways, and the NF-kappa B activation cascade--mediate the effects of other inducers as well. However, the molecules that initiate these signaling events, including the death domain- and TNF receptor associated factor (TRAF) domain-containing adapter proteins and the signaling enzymes associated with them, are largely unique to the TNF/nerve growth factor receptor family.
Similar articles
- Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease.
Gruss HJ, Duyster J, Herrmann F. Gruss HJ, et al. Ann Oncol. 1996;7 Suppl 4:19-26. doi: 10.1093/annonc/7.suppl_4.s19. Ann Oncol. 1996. PMID: 8836404 Review. - Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
Warzocha K, Bienvenu J, Coiffier B, Salles G. Warzocha K, et al. Eur Cytokine Netw. 1995 Mar-Apr;6(2):83-96. Eur Cytokine Netw. 1995. PMID: 7578992 Review. - Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
Choi YJ, Baranowska-Daca E, Nguyen V, Koji T, Ballantyne CM, Sheikh-Hamad D, Suki WN, Truong LD. Choi YJ, et al. Kidney Int. 2000 Oct;58(4):1481-91. doi: 10.1046/j.1523-1755.2000.00310.x. Kidney Int. 2000. PMID: 11012883 - Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling.
Sessler T, Healy S, Samali A, Szegezdi E. Sessler T, et al. Pharmacol Ther. 2013 Nov;140(2):186-99. doi: 10.1016/j.pharmthera.2013.06.009. Epub 2013 Jul 8. Pharmacol Ther. 2013. PMID: 23845861 Review. - Intracellular signals and events activated by cytokines of the tumor necrosis factor superfamily: From simple paradigms to complex mechanisms.
Grivennikov SI, Kuprash DV, Liu ZG, Nedospasov SA. Grivennikov SI, et al. Int Rev Cytol. 2006;252:129-61. doi: 10.1016/S0074-7696(06)52002-9. Int Rev Cytol. 2006. PMID: 16984817 Review.
Cited by
- Continuous TNF-α exposure in mammary epithelial cells promotes cancer phenotype acquisition via EGFR/TNFR2 activation.
Lee JH, Hallis SP, Kwak MK. Lee JH, et al. Arch Pharm Res. 2024 May;47(5):465-480. doi: 10.1007/s12272-024-01497-y. Epub 2024 May 11. Arch Pharm Res. 2024. PMID: 38734854 - Glutamine-mediated Modulation of XO/uric acid/NF-kB Signaling Pathway Ameliorates Intestinal I/R-induced Bacterial Translocation and Cardiorenal Inflammatory Injury.
Hamed MA, Adegboyega OO, Ojo OI, Akhigbe TM, Fajuyitan FD, Adeyemo OC, Odebunmi TF, Adeniyi OS, Omole IA, Akhigbe RE. Hamed MA, et al. Cell Biochem Biophys. 2024 Jun;82(2):1007-1018. doi: 10.1007/s12013-024-01252-6. Epub 2024 Mar 26. Cell Biochem Biophys. 2024. PMID: 38530591 - The TGF-β superfamily as potential therapeutic targets in pancreatic cancer.
Tindall RR, Bailey-Lundberg JM, Cao Y, Ko TC. Tindall RR, et al. Front Oncol. 2024 Mar 4;14:1362247. doi: 10.3389/fonc.2024.1362247. eCollection 2024. Front Oncol. 2024. PMID: 38500662 Free PMC article. Review. - Carnosol ameliorated cancer cachexia-associated myotube atrophy by targeting P5CS and its downstream pathways.
Fang QY, Wang YP, Zhang RQ, Fan M, Feng LX, Guo XD, Cheng CR, Zhang XW, Liu X. Fang QY, et al. Front Pharmacol. 2024 Jan 5;14:1291194. doi: 10.3389/fphar.2023.1291194. eCollection 2023. Front Pharmacol. 2024. PMID: 38249348 Free PMC article. - The TNFα/TNFR2 axis mediates natural killer cell proliferation by promoting aerobic glycolysis.
Khan AUH, Ali AK, Marr B, Jo D, Ahmadvand S, Fong-McMaster C, Almutairi SM, Wang L, Sad S, Harper ME, Lee SH. Khan AUH, et al. Cell Mol Immunol. 2023 Oct;20(10):1140-1155. doi: 10.1038/s41423-023-01071-4. Epub 2023 Aug 9. Cell Mol Immunol. 2023. PMID: 37553427 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous